---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-024762"
form_type: "8-K"
ticker: "DMAA"
cik: "0002028614"
company_name: "Drugs Made In America Acquisition Corp."
filed_at: "2026-03-06T23:59:59+00:00"
generated_at: "2026-05-15T19:04:37.335100+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Drugs Made In America confirms trust account intact after affiliate irregularities

## Summary
- Sponsor made improper withdrawals from affiliate's working capital account between Sept 26, 2025 and Dec 31, 2025.
- Board immediately acted; irregularities did not extend to the company's trust account.
- As of March 6, 2026, trust account holds approximately $241,292,436.
- No details on amount of irregularity or actions against sponsor disclosed.

## SEC filing metadata
- accession: 0001213900-26-024762
- form_type: 8-K
- ticker: DMAA
- cik: 0002028614
- company_name: Drugs Made In America Acquisition Corp.
- filed_at: 2026-03-06T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2028614/000121390026024762/0001213900-26-024762-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2028614/000121390026024762/ea028047001-8k_drugscorp.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-024762
- JSON: https://secwatch.observer/filing/0001213900-26-024762.json
- Plain text: https://secwatch.observer/filing/0001213900-26-024762.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.